Jennifer L McLaren1, Mary F Brunette1, Gregory J McHugo1, Robert E Drake1, William B Daviss1. 1. Dr. McLaren, Dr. Brunette, and Dr. Daviss are with the Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Dr. McHugo is with the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon. Dr. Drake is with the IPS Employment Center, Westat, Inc., Lebanon.
Abstract
OBJECTIVE: The survey assessed self-reported monitoring by child psychiatrists of children prescribed second-generation antipsychotics, facilitators and barriers to monitoring, and steps taken to adhere to monitoring. METHODS: The authors anonymously surveyed 4,144 U.S. child psychiatrists. Descriptive statistics and multiple linear regressions were utilized to describe results and identify correlates of monitoring. RESULTS: Among responders (N=1,314, 32%), over 95% were aware of all guidelines, over 80% agreed with most guidelines, but less than 20% had adopted and adhered to most guidelines. Awareness of guidelines, working within an academic practice, and fewer years in practice predicted adherence. CONCLUSIONS: Child psychiatrists have generally not adopted the guidelines for monitoring children on second-generation antipsychotics. Interventions to improve monitoring should target child psychiatrists in nonacademic practices and those who have been out of training for longer periods. Future research should assess family barriers to monitoring.
OBJECTIVE: The survey assessed self-reported monitoring by child psychiatrists of children prescribed second-generation antipsychotics, facilitators and barriers to monitoring, and steps taken to adhere to monitoring. METHODS: The authors anonymously surveyed 4,144 U.S. child psychiatrists. Descriptive statistics and multiple linear regressions were utilized to describe results and identify correlates of monitoring. RESULTS: Among responders (N=1,314, 32%), over 95% were aware of all guidelines, over 80% agreed with most guidelines, but less than 20% had adopted and adhered to most guidelines. Awareness of guidelines, working within an academic practice, and fewer years in practice predicted adherence. CONCLUSIONS:Child psychiatrists have generally not adopted the guidelines for monitoring children on second-generation antipsychotics. Interventions to improve monitoring should target child psychiatrists in nonacademic practices and those who have been out of training for longer periods. Future research should assess family barriers to monitoring.
Authors: Robert O Cotes; Nisha K Fernandes; Jennifer L McLaren; Gregory J McHugo; Stephen J Bartels; Mary F Brunette Journal: J Child Adolesc Psychopharmacol Date: 2017-06-05 Impact factor: 2.576
Authors: Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra Journal: J Clin Psychopharmacol Date: 2021 Jan/Feb 01 Impact factor: 3.118
Authors: Lenneke Minjon; Ivona Brozina; Toine C G Egberts; Eibert R Heerdink; Els van den Ban Journal: Front Psychiatry Date: 2021-02-25 Impact factor: 4.157
Authors: Lenneke Minjon; Els van den Ban; Marloes T Bazelier; Arief Lalmohamed; Toine C G Egberts; Eibert R Heerdink Journal: J Child Adolesc Psychopharmacol Date: 2021-10-07 Impact factor: 2.576